Related Experiment Video
Updated: Jan 2, 2026

Knee Arthrocentesis in Adults
Published on: February 25, 2022
Diagnosis and treatment of mycoplasmal septic arthritis: a systematic review
1Department of Orthopedic Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350004, China.
Purpose:
Septic arthritis caused by Mycoplasma is rare. The diagnosis and effective treatment of mycoplasmal septic arthritis remains a serious problem for clinicians. The aim of this systematic review was to document the available evidence on the diagnosis and treatment methods for mycoplasmal septic arthritis and to provide guidance for clinicians.
Methods:
The PubMed, EMBASE, and Cochrane Library databases were searched in December 2018.The searches were limited to the English language. Article screening and data extraction and compilation were conducted by two independent reviewers. All the included studies were assessed using the Methodological Index for Non-randomized Studies (MINORS) tool.
Results:
There was a total of 33 articles including 34 cases of mycoplasmal septic arthritis and eight of them were periprosthetic joint infection (PJI). Twenty-four patients (70.6%) were immunocompromised, and the synovial fluid white blood cell (WBC) count was significantly lower in the immunocompromised group than in the immunocompetent group (48,527 × 106/L vs. 100,640 × 106/L; P = 0.009). The traditional culture method took longer, and the positivity rate was lower than that of nucleic acid testing (50% vs. 100%; P = 0.016). Only 19.2% (5/26) of patients treated with empiric antibiotics were relieved of symptoms, while 82.4% (28/34) of patients achieved satisfactory results after being treated with antibiotics against Mycoplasma.
Conclusion:
The possibility of mycoplasmal septic arthritis should be considered if patients with joint infections have a history of immunocompromised, repeated negative cultures, and poor empiric antibiotic treatment results. The rational use of nucleic acid testing technologies can help in the clinical diagnosis and treatment of mycoplasmal septic arthritis.
Insights
Mycoplasma septic arthritis is rare but challenging to diagnose and treat. Nucleic acid testing improves diagnosis, and targeted antibiotics are more effective than empiric treatment for this infection.
Area of Science:
- Infectious Diseases
- Rheumatology
- Microbiology
Background:
- Septic arthritis caused by Mycoplasma is uncommon, posing diagnostic and therapeutic challenges for clinicians.
- Effective management strategies for mycoplasmal septic arthritis are crucial due to its rarity and difficulty in diagnosis.
Purpose of the Study:
- To systematically review existing evidence on diagnosing and treating mycoplasmal septic arthritis.
- To provide clinical guidance for healthcare professionals managing this rare joint infection.
Main Methods:
- A systematic review of PubMed, EMBASE, and Cochrane Library databases (search until December 2018).
- Inclusion of English-language articles, with independent reviewer screening and data extraction.
- Assessment of study quality using the Methodological Index for Non-randomized Studies (MINORS) tool.
Main Results:
- Analysis of 33 articles detailing 34 cases of mycoplasmal septic arthritis, including 8 periprosthetic joint infections (PJI).
- Immunocompromised patients (70.6%) showed significantly lower synovial fluid white blood cell (WBC) counts.
- Nucleic acid testing demonstrated higher positivity (100%) and faster results compared to traditional culture (50%).
- Targeted antibiotic therapy against Mycoplasma yielded better outcomes (82.4%) than empiric antibiotics (19.2%).
Conclusions:
- Consider mycoplasmal septic arthritis in immunocompromised patients with joint infections, negative cultures, and poor response to empiric antibiotics.
- Nucleic acid testing is a valuable tool for accurate clinical diagnosis of mycoplasmal septic arthritis.
- Tailored antibiotic treatment based on specific Mycoplasma identification improves patient outcomes.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis III: Medical Management
Acute Pyelonephritis I: Introduction
Pericarditis III: Medical Management
Rheumatic Heart Disease III: Medical Management
Tonsillitis II: Management

